Search All News
Columbia researchers have developed a new algorithm to better identify safety signals of prescribed drugs in different stages of childhood.
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
A study of more than 500 hospitalized COVID patients found that comorbidities do not necessarily result in the worst outcomes.
A collaboration between Observational Health Data Sciences and Informatics (OHDSI) and Health Level Seven International (HL7) will improve access and sharing of health care data among researchers.
- December 22, 2020
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.
- December 18, 2020
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
- December 2, 2020
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
- October 27, 2020
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
- October 2, 2020
New data mining techniques are uncovering previously hidden adverse drug effects that impact women more than men.
- July 6, 2020
With high precision, a new algorithm predicts which patients treated for traumatic injuries in the emergency department will later develop post-traumatic stress disorder.
- June 8, 2020
Kidney complications were more common in New York City COVID-19 patients than in COVID-19 patients from other regions, a new single-center study from Columbia researchers has found.
- May 15, 2020
Columbia University's new "COVID-19 Trial Finder" is a simplified method for patients, clinicians, and healthy volunteers to find appropriate COVID clinical trials near their home.
- March 24, 2020
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.